#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13932	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2117	654.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1458	1458	C	860	C,T	810,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25686	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3616	708.8	0	.	n	.	0	T695C	SNP	695	695	T	1031	1031	C	782	C,T	731,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25686	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3616	708.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1673	1673	A	793	A,G	739,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25686	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3616	708.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2307	2307	C	868	C	794	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25686	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3616	708.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2381	2381	A	843	A	799	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25686	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3616	708.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2933	2933	C	790	C	743	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	6	blaTEM	861	201	100.0	blaTEM.l15.c30.ctg.1	252	1.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	1884	folP	855	855	100.0	folP.l6.c30.ctg.1	1533	122.3	1	SNP	p	R229S	0	.	.	685	687	CGC	1030	1032	CGC	181;178;179	C;G;C	170;169;170	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4698	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3467	135.1	1	SNP	p	S91F	0	.	.	271	273	TCC	621	623	TCC	178;179;181	T;C;C	166;168;169	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4698	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3467	135.1	1	SNP	p	D95N	0	.	.	283	285	GAC	633	635	GAC	178;177;177	G;A;C	167;167;168	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4698	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3467	135.1	1	SNP	p	D95G	0	.	.	283	285	GAC	633	635	GAC	178;177;177	G;A;C	167;167;168	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1508	mtrR	633	633	99.68	mtrR.l15.c17.ctg.1	1323	113.6	0	.	p	.	0	S32W	NONSYN	94	96	TCG	421	423	TGG	186;183;183	T;G;G	175;176;175	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1508	mtrR	633	633	99.68	mtrR.l15.c17.ctg.1	1323	113.6	0	.	p	.	0	D79N	NONSYN	235	237	GAT	562	564	AAT	174;174;177	A;A;T,G	162;162;164,1	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1508	mtrR	633	633	99.68	mtrR.l15.c17.ctg.1	1323	113.6	1	SNP	p	G45D	0	.	.	133	135	GGC	460	462	GGC	192;194;196	G;G;C	182;183;184	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	796	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	994	79.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4930	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2956	166.3	1	SNP	p	D86N	0	.	.	256	258	GAC	639	641	GAC	199;200;200	G;A;C	187;187;190	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4930	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2956	166.3	1	SNP	p	S88P	0	.	.	262	264	TCC	645	647	TCC	194;192;193	T;C;C	184;183;183	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3968	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2607	151.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1513	1515	GGC	158;157;154	G,C;G;C	149,1;147;146	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3576	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2441	146.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1312	1314	GCA	194;197;200	G;C;A	180;182;187	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3576	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2441	146.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1315	1317	ATC	197;197;196	A;T;C	186;183;183	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3576	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2441	146.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1327	1329	GTG	205;206;206	G;T,G;G	195;194,1;195	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3576	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2441	146.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1327	1329	GTG	205;206;206	G;T,G;G	195;194,1;195	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3576	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2441	146.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1831	1833	ACC	166;167;167	A;C;C,T	155;159;159,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3576	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2441	146.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1885	1887	GCG	164;164;165	G;C;G	148;140;142	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3576	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2441	146.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1885	1887	GCG	164;164;165	G;C;G	148;140;142	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3576	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2441	146.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2008	2010	GGC	135;132;133	G;G;C	123;122;123	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3576	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2441	146.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2017	2019	GGC	138;135;134	G;G;C	126;123;119	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3576	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2441	146.2	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2035	2037	CTG	154;156;157	C,G;T,G;G	120,4;119,1;123	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5116	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3044	167.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1557	1559	CCG	163;161;160	C;C,T;G	144;148,1;147	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1968	porA	1146	1146	99.83	porA.l6.c30.ctg.1	1846	105.9	0	.	p	.	0	S22G	NONSYN	64	66	AGC	428	430	GGC	144;145;146	G,A;G;C	136,1;134;137	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1968	porA	1146	1146	99.83	porA.l6.c30.ctg.1	1846	105.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	610	610	C	154	C	136	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	319	90.12	porB1a.l15.c17.ctg.2	463	27.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	166	168	AAT	14;14;14	A;A;T	14;14;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	319	90.12	porB1a.l15.c17.ctg.2	463	27.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	169	171	AAT	14;14;13	A;A;T	14;14;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	319	90.12	porB1a.l15.c17.ctg.2	463	27.6	0	.	p	.	0	A222V	NONSYN	664	666	GCT	181	183	GTT	14;14;14	G;T;T	14;14;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	319	90.12	porB1a.l15.c17.ctg.2	463	27.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	193	195	GCA	18;18;18	G;C;A	18;18;18	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	319	90.12	porB1a.l15.c17.ctg.2	463	27.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	216	218	GTA	18;18;18	G;T;A	18;18;18	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	294	porB1a	984	319	90.12	porB1a.l15.c17.ctg.2	463	27.6	0	.	p	.	0	N237fs	FSHIFT	709	709	A	225	225	A	16	A	16	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2638	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1609	163.0	0	.	p	.	0	T18M	NONSYN	52	54	ACG	478	480	ATG	214;213;212	A;T;G	196;198;195	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2638	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1609	163.0	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	853	855	CAA	211;213;213	C;A;A	200;203;205	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2638	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1609	163.0	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1060	1062	GAT	243;246;242	G;A;T	225;227;223	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2638	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1609	163.0	0	.	p	.	0	H213G	NONSYN	637	639	CAT	1063	1065	GGT	241;240;244	G;G;T	223;222;225	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2638	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1609	163.0	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1069	1071	GCT	242;241;235	G;C;T	222;221;219	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2638	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1609	163.0	0	.	p	.	0	S220T	NONSYN	658	660	AGC	1084	1086	ACT	229;231;233	A;C;T	208;212;211	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2638	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1609	163.0	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1195	1197	ATG	219;217;219	A;T;G	204;202;204	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2638	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1609	163.0	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1198	1200	AGC	220;220;221	A;G;C	207;207;208	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2638	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1609	163.0	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1201	1203	GGT	220;219;216	G;G;T	207;205;200	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2638	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1609	163.0	1	SNP	p	G120K	0	.	.	358	360	GGC	784	786	GGC	216;215;215	G;G;C	205;207;206	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10464	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4844	215.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1044	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1188	87.6	1	SNP	p	V57M	1	.	.	169	171	ATG	594	596	ATG	240;240;241	A;T;G	226;226;227	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	M177T	NONSYN	529	531	ATG	834	836	ACG	387;383;383	A;C;G	370;367;369	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	855	857	GAC	334;333;329	G;A;C	333;329;328	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	T190M	NONSYN	568	570	ACG	873	875	ATG	336;333;333	A;T;G	336;333;333	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	L194S	NONSYN	580	582	TTA	885	887	TCA	326;320;319	T;C;A	326;320;319	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	930	932	CAG	301;304;304	C;A,G;G	295;299,1;299	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	V216L	NONSYN	646	648	GTT	951	953	CTT	306;303;304	C;T;T	306;303;304	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	N223S	NONSYN	667	669	AAC	972	974	AGT	301;307;309	A;G;T	296;302;293	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1041	1043	CCG	430;434;438	C;C;G	406;412;415	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1143	1145	TCG	512;511;513	T;C,T;G	475;472,1;478	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1314	1316	AAA	260;255;252	A;A;A	254;250;249	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1317	1319	AAG	248;243;242	A;A;G	246;241;239	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1332	1334	CAC	218;215;215	C;A;C	218;209;214	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1371	1373	GAA	217;219;217	G;A,T;A	213;217,1;216	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1449	1451	ACG	150;150;150	A,T;C;G	146,1;147;149	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1500	1502	ATT	242;243;244	A;T;T	229;228;231	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1503	1505	AGT	244;241;243	A;G;T	231;228;228	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1542	1544	CTA	284;286;288	C;T,C;A	262;265,1;269	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1584	1586	AAT	177;178;176	A;A;T	172;173;173	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1653	1655	TCA	223;224;223	T;C;A	221;219;216	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1677	1679	ATG	233;230;233	A;T;G	231;228;230	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	1971	1973	ACC	550;546;546	A;C;C	516;517;511	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9192	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2568	356.7	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2067	2069	GAA	528;528;529	G;A;A	505;506;505	.	Tetracycline resistance
